Difference between revisions of "Category:GnRH agonists"
Jump to navigation
Jump to search
m |
Warner-admin (talk | contribs) m (Text replacement - "Category:Endocrine therapy" to "Category:Endocrine therapeutic") |
||
| Line 1: | Line 1: | ||
Gonadotropin-releasing hormone agonists, generally used for antineoplastic effect in hormone-dependent cancers, e.g. [[prostate cancer]] and [[breast cancer]]. Also sometimes referred to as leutenizing hormone-releasing hormone (LHRH) agonists. | Gonadotropin-releasing hormone agonists, generally used for antineoplastic effect in hormone-dependent cancers, e.g. [[prostate cancer]] and [[breast cancer]]. Also sometimes referred to as leutenizing hormone-releasing hormone (LHRH) agonists. | ||
| − | [[Category:Endocrine | + | [[Category:Endocrine therapeutic]] |
Revision as of 17:34, 3 February 2019
Gonadotropin-releasing hormone agonists, generally used for antineoplastic effect in hormone-dependent cancers, e.g. prostate cancer and breast cancer. Also sometimes referred to as leutenizing hormone-releasing hormone (LHRH) agonists.
Pages in category "GnRH agonists"
The following 4 pages are in this category, out of 4 total.